Cargando…

Survival benefit evaluation of radiotherapy in esophageal cancer patients aged 80 and older

PURPOSE: To evaluate the survival benefit of radiotherapy (RT) in esophageal cancer (EC) patients aged ≥ 80. MATERIALS AND METHODS: Records for all EC patients aged ≥ 65 years were extracted from the Surveillance, Epidemiology, and End Results database. Chi-square test compared the characteristic an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Shan, Zheng, Shuyu, Gong, Tuotuo, Ma, Hongbing, Ke, Yue, Zhao, Songchuan, Wang, Wenyu, Jia, Lijun, Zhang, Xiaozhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762382/ https://www.ncbi.nlm.nih.gov/pubmed/29340114 http://dx.doi.org/10.18632/oncotarget.22884

Ejemplares similares

High mobility group box 1 promotes radioresistance in esophageal squamous cell carcinoma cell lines by modulating autophagy
por: Ma, Hongbing, et al.
Publicado: (2019)

PTENP1 inhibits the growth of esophageal squamous cell carcinoma by regulating SOCS6 expression and correlates with disease prognosis
por: Gong, Tuotuo, et al.
Publicado: (2017)

Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells
por: Fu, Shenbo, et al.
Publicado: (2018)

Survival benefit of radiotherapy in metastatic esophageal cancer: a population-based study
por: Li, Xiangpan, et al.
Publicado: (2019)

Identification of m(5)C-related lncRNAs signature to predict prognosis and therapeutic responses in esophageal squamous cell carcinoma patients
por: Ma, Yuan, et al.
Publicado: (2023)

Silencing UHRF1 Enhances Radiosensitivity of Esophageal Squamous Cell Carcinoma by Inhibiting the PI3K/Akt/mTOR Signaling Pathway
por: Hui, Beina, et al.
Publicado: (2021)

SOCS6 promotes radiosensitivity and decreases cancer cell stemness in esophageal squamous cell carcinoma by regulating c-Kit ubiquitylation
por: Sun, Xuanzi, et al.
Publicado: (2021)

Human papillomavirus 16 infection predicts poor outcome in patients with esophageal squamous cell carcinoma
por: Xi, Ruxing, et al.
Publicado: (2015)

Genome-wide analysis of lncRNAs, miRNAs, and mRNAs forming a prognostic scoring system in esophageal squamous cell carcinoma
por: Shi, Xiaobo, et al.
Publicado: (2020)

Clinical response to chemoradiotherapy in esophageal carcinoma is associated with survival and benefit of consolidation chemotherapy
por: Zhao, Zongxing, et al.
Publicado: (2020)

No survival benefit could be obtained from adjuvant radiotherapy in esophageal cancer treated with neoadjuvant chemotherapy followed by surgery: A SEER-based analysis
por: Zheng, Si-Yue, et al.
Publicado: (2022)

Carbon ion radiotherapy for 80 years or older patients with hepatocellular carcinoma
por: Shiba, Shintaro, et al.
Publicado: (2017)

Neuroendocrine carcinoma of esophageal and gastric cardia: clinicopathologic and immunohistochemistry study of 80 cases
por: Hong, Liangli, et al.
Publicado: (2017)

Clinical values of Ku80 upregulation in superficial esophageal squamous cell carcinoma
por: Wang, Shuai, et al.
Publicado: (2018)

Nomogram predicts survival benefit for non- metastatic esophageal cancer patients who underwent preoperative radiotherapy
por: Xie, Kenan, et al.
Publicado: (2018)

Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools
por: Liu, Jiaxin, et al.
Publicado: (2019)

Correction to: Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools
por: Liu, Jiaxin, et al.
Publicado: (2019)

Examination of the expression and prognostic significance of DLGAPs in gastric cancer using the TCGA database and bioinformatic analysis
por: Liu, Jiaxin, et al.
Publicado: (2018)

Assessment of photodynamic therapy as a salvage treatment for local failure after chemoradiotherapy or radiotherapy for esophageal cancer in patients aged 80 years or older
por: Nishikawa, Michiko, et al.
Publicado: (2022)

Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer
por: Yao, Yi, et al.
Publicado: (2019)

Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma
por: Wu, Haishan, et al.
Publicado: (2021)

Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapy
por: Gao, Lin-Rui, et al.
Publicado: (2022)

HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo
por: Xi, Ruxing, et al.
Publicado: (2016)

Radiotherapy for esophageal carcinoma: dose, response and survival
por: Luo, Yijun, et al.
Publicado: (2017)

Immediate and Long-Term Results of Coronary Angioplasty in Patients Aged 80 Years and Older
por: Chen, Bo, et al.
Publicado: (2010)

Outcomes of Treated Hypertension at Age 80 and Older: Cohort Analysis of 79,376 Individuals
por: Delgado, João, et al.
Publicado: (2016)

Postoperative Radiotherapy Contributes to the Survival Benefit of Breast-Conserving Therapy over Mastectomy
por: Chen, Chu-Ying, et al.
Publicado: (2022)

The Effect of the Appropriate Timing of Radiotherapy on Survival Benefit in Patients with Metastatic Esophageal Cancer Who Have Undergone Resection of Primary Site: A SEER Database Analysis
por: Qiu, Bingzhe, et al.
Publicado: (2022)

Identification and validation of an autophagy-related gene signature for predicting prognosis in patients with esophageal squamous cell carcinoma
por: Shi, Xiaobo, et al.
Publicado: (2022)

The Intensity of Radiotherapy-Elicited Immune Response Is Associated with Esophageal Cancer Clearance
por: Ma, Jin-lu, et al.
Publicado: (2014)

Aberrant methylation and microRNA-target regulation are associated with downregulated NEURL1B: a diagnostic and prognostic target in colon cancer
por: Liu, Jiaxin, et al.
Publicado: (2020)

Doses of intensity-modulated radiotherapy and its association with cardiac disease in esophageal cancer patients
por: Zhang, Jiandong, et al.
Publicado: (2021)

Survival and Symptom Relief after Palliative Radiotherapy for Esophageal Cancer
por: Welsch, Julia, et al.
Publicado: (2016)

Survival Impact of Delaying Postoperative Radiotherapy in Patients with Esophageal Cancer
por: Wang, Yuanyuan, et al.
Publicado: (2018)

Survival benefit of surgery to patients with esophageal squamous cell carcinoma
por: Chen, Miao-Fen, et al.
Publicado: (2017)

Chemoradiotherapy vs radiotherapy for nonoperative early stage esophageal cancer: A seer data analysis
por: Li, Jiaxin, et al.
Publicado: (2020)

A Novel Autophagy-Related Long Non-Coding RNA Signature to Predict Prognosis and Therapeutic Response in Esophageal Squamous Cell Carcinoma
por: Shi, Xiaobo, et al.
Publicado: (2021)

Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas
por: Li, Depei, et al.
Publicado: (2019)

Survival benefit of surgery with radiotherapy vs surgery alone to patients with T2-3N0M0 stage esophageal adenocarcinoma
por: Song, Yaqi, et al.
Publicado: (2016)

Comparison  of  efficacy, safety, and costs between neoadjuvant hypofractionated radiotherapy and conventionally fractionated radiotherapy for esophageal carcinoma
por: Lyu, Jiahua, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_av33omkl2osi6qm4p0t5ri5oe0